MedPath

Cormatrix Cardiovascular, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:1

Trial Phases

1 Phases

Not Applicable:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Not Applicable
3 (100.0%)

CorMatrix Cor TRICUSPID ECM Valve Replacement - Pivotal Study

Not Applicable
Recruiting
Conditions
Tricuspid Valve Disease
Tricuspid Valve Insufficiency
First Posted Date
2023-02-24
Last Posted Date
2024-03-18
Lead Sponsor
CorMatrix Cardiovascular, Inc.
Target Recruit Count
92
Registration Number
NCT05742906
Locations
🇺🇸

St Francis Hospital, Indianapolis, Indiana, United States

🇺🇸

Columbia University Irving Medical Center/New York Presbyterian, New York, New York, United States

CorMatrix Cor TRICUSPID ECM Valve Replacement Study

Not Applicable
Recruiting
Conditions
Tricuspid Valve Disease
First Posted Date
2015-03-25
Last Posted Date
2023-01-26
Lead Sponsor
CorMatrix Cardiovascular, Inc.
Target Recruit Count
78
Registration Number
NCT02397668
Locations
🇺🇸

Springhill Memorial Hospital, Mobile, Alabama, United States

🇺🇸

St Francis Hospital, Indianapolis, Indiana, United States

🇺🇸

Cincinnati Children's Hospital, Cincinnati, Ohio, United States

Restore Myocardial Function With CorMatrix® ECM® Particulate (P-ECM)

Not Applicable
Completed
Conditions
Heart Failure
First Posted Date
2014-05-15
Last Posted Date
2017-07-19
Lead Sponsor
CorMatrix Cardiovascular, Inc.
Target Recruit Count
9
Registration Number
NCT02139189
Locations
🇵🇱

Central Clinical Hospital of the Ministry of the Interior in Warsaw, Warsaw, Poland

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.